Senior-friendly CRP testing protocol withheld by CPSC to respond to comments.
SENIOR-FRIENDLY CRP TESTING FINAL RULE WITHHELD BY CPSC to address comments submitted by the Coalition for Responsible Packaging. In a Feb. 21 Federal Register notice, the Consumer Product Safety Commission said it voted Feb. 8 to "withhold publication of the final rule in order to consider these new arguments." The commission voted Jan. 6 to amend the child-resistant packaging requirements under the Poison Prevention Packaging Act (PPPA) of 1970 to include adults aged 60-75 in the testing protocol ("The Tan Sheet" Jan. 9, p. 11).
More from Archive
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
More from Pink Sheet
Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.
The UK’s research-based pharma industry and medical research charities have set out clear action points to drive greater diversity and inclusion in clinical trials.
Blenrep, GSK’s multiple myeloma therapy, faced a major setback when it was withdrawn from the market in 2022. The drug has since made a return as a second-line therapy, and is on track to being reimbursed in England.